☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Type 1 Spinal Muscular Atrophy
Roche Report Results of Evrysdi (risdiplam) in FIREFISH Study for Infants with Type 1 SMA
February 25, 2021
Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA
September 28, 2020
Roche Reports Results of Risdiplam in FIREFISH Study for Infants with Type 1 Spinal Muscular Atrophy
January 23, 2020
Load more...
Back to Home